Skip to Main Content

Paper Details

A way forward for cancer prevention therapy: personalized risk assessment.
Oncotarget
2
2019
Author NameAffiliation
Motomi MoriKnight Cancer Institute, Oregon Health & Science University
Motomi MoriOHSU-PSU School of Public Health, Oregon Health & Science University
  • 1 - 2

Datasets

Release 1.2